- preweaning lethality, incomplete penetrance / IMPC
- enlarged spleen / IMPC
- enlarged cecum / IMPC
- hyperactivity / IMPC
- abnormal skin morphology / IMPC
- decreased thigmotaxis / IMPC
- edema / IMPC
- abnormal behavior / IMPC
- abnormal spleen morphology / IMPC
- abnormal kidney morphology / IMPC
- preweaning lethality, complete penetrance / IMPC
- small kidney / IMPC
- abnormal cecum morphology / IMPC
- increased bone mineral content / IMPC
- abnormal skin morphology / IMPC
B6.129-Cnr1tm1Zim Cnr2tm1Zim/Ieg
Status | Available to order |
EMMA ID | EM:02273 |
International strain name | B6.129-Cnr1tm1Zim Cnr2tm1Zim/Ieg |
Alternative name | Cnr1 tm1zim/ Cnr2 tm2zim |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Cnr1tm1Zim, Cnr2tm1Zim |
Gene/Transgene symbol | Cnr1, Cnr2 |
Information from provider
Provider | Andreas Zimmer |
Provider affiliation | Institute of Molecular Psychiatry |
Genetic information | See references: PubMed_ID 10318961 and PubMed_ID 10822068. |
Phenotypic information | Allergic contact dermatitis. |
References |
|
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | homozygous C57BL/6N |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- hypoactivity / MGI
- increased circulating corticosterone level / MGI
- increased thermal nociceptive threshold / MGI
- premature death / MGI
- decreased vertical activity / MGI
- catalepsy / MGI
- hypoalgesia / MGI
- maternal effect / MGI
- increased follicle stimulating hormone level / MGI
- increased circulating estradiol level / MGI
- decreased circulating progesterone level / MGI
- increased chemical nociceptive threshold / MGI
- decreased survivor rate / MGI
- impaired behavioral response to addictive substance / MGI
- postnatal lethality, incomplete penetrance / MGI
- early parturition / MGI
- abnormal macrophage physiology / MGI
- immune system phenotype / MGI
- reproductive system phenotype / MGI
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- abnormal cerebral cortex morphology / MGI
- decreased body weight / MGI
- weight loss / MGI
- increased aggression towards mice / MGI
- increased anxiety-related response / MGI
- hyperactivity / MGI
- hypoactivity / MGI
- increased exploration in new environment / MGI
- decreased exploration in new environment / MGI
- abnormal cued conditioning behavior / MGI
- reduced long term depression / MGI
- increased circulating corticosterone level / MGI
- increased circulating adrenocorticotropin level / MGI
- absent long term depression / MGI
- increased thermal nociceptive threshold / MGI
- increased chemically-elicited antinociception / MGI
- decreased chemically-elicited antinociception / MGI
- abnormal learning/memory/conditioning / MGI
- premature death / MGI
- no abnormal phenotype detected / MGI
- abnormal social/conspecific interaction / MGI
- abnormal sperm motility / MGI
- decreased circulating insulin level / MGI
- decreased vertical activity / MGI
- abnormal active avoidance behavior / MGI
- catalepsy / MGI
- increased insulin sensitivity / MGI
- increased susceptibility to pharmacologically induced seizures / MGI
- abnormal excitatory postsynaptic potential / MGI
- decreased synaptic depression / MGI
- abnormal paired-pulse facilitation / MGI
- abnormal inhibitory postsynaptic currents / MGI
- enhanced long term potentiation / MGI
- no phenotypic analysis / MGI
- hypoalgesia / MGI
- increased susceptibility to ischemic brain injury / MGI
- abnormal depression-related behavior / MGI
- abnormal response to novel object / MGI
- nervous system phenotype / MGI
- abnormal nervous system morphology / MGI
- abnormal nervous system physiology / MGI
- maternal effect / MGI
- abnormal nervous system development / MGI
- abnormal sweet taste sensitivity / MGI
- abnormal neuron physiology / MGI
- abnormal synaptic plasticity / MGI
- abnormal neuronal precursor proliferation / MGI
- increased follicle stimulating hormone level / MGI
- increased circulating estradiol level / MGI
- decreased circulating progesterone level / MGI
- behavior/neurological phenotype / MGI
- skeleton phenotype / MGI
- abnormal food intake / MGI
- decreased percent body fat/body weight / MGI
- decreased susceptibility to diet-induced obesity / MGI
- decreased circulating leptin level / MGI
- increased cerebral infarction size / MGI
- increased susceptibility to neuronal excitotoxicity / MGI
- increased chemical nociceptive threshold / MGI
- decreased survivor rate / MGI
- increased physiological sensitivity to xenobiotic / MGI
- abnormal axon fasciculation / MGI
- impaired cued conditioning behavior / MGI
- anhedonia / MGI
- impaired conditioned place preference behavior / MGI
- impaired behavioral response to xenobiotic / MGI
- impaired behavioral response to addictive substance / MGI
- impaired behavioral response to morphine / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- increased sensitivity to xenobiotic induced morbidity/mortality / MGI
- increased behavioral withdrawal response / MGI
- decreased total body fat amount / MGI
- abnormal bone mineral density / MGI
- postnatal lethality, incomplete penetrance / MGI
- early parturition / MGI
- alopecia / MGI
- abnormal macrophage physiology / MGI
- immune system phenotype / MGI
- reproductive system phenotype / MGI
Literature references
- Attenuation of allergic contact dermatitis through the endocannabinoid system.;Karsak Meliha, Gaffal Evelyn, Date Rahul, Wang-Eckhardt Lihua, Rehnelt Jennifer, Petrosino Stefania, Starowicz Katarzyna, Steuder Regina, Schlicker Eberhard, Cravatt Benjamin, Mechoulam Raphael, Buettner Reinhard, Werner Sabine, Di Marzo Vincenzo, Tüting Thomas, Zimmer Andreas, ;2007;Science (New York, N.Y.);316;1494-7; 17556587
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.;Járai Z, Wagner J A, Varga K, Lake K D, Compton D R, Martin B R, Zimmer A M, Bonner T I, Buckley N E, Mezey E, Razdan R K, Zimmer A, Kunos G, ;1999;Proceedings of the National Academy of Sciences of the United States of America;96;14136-41; 10570211
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).